MedPath

Dynamics of circulating tumor DNA (ctDNA) and extracellular vesicle (EVs) for diagnosis, therapy monitoring, and prognosis assessment in solid visceral tumors.

Phase 1
Recruiting
Conditions
C15
C18
C19
C22
C23
C24
C25
C26
C49
C16
Registration Number
DRKS00028154
Lead Sponsor
niversitätklinikum Münster (UKM) Klinik füt Allgemein-, Viszeral- und Transplantationschirurgie. Direktor: Univ.-Prof. Dr. med. A. Pascher, MBA, FEBS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

curative intended surgery

Exclusion Criteria

Infectivity (HCV, HBV, HIV)
CED
Condition after transplantation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The correlation between ctDNA/EVs dynamics in patients before and after curative-intent surgery with the recurrence rate and overall survival.
Secondary Outcome Measures
NameTimeMethod
ctDNA/EVs as diagnostic markers in patients with solid visceral tumors.
© Copyright 2025. All Rights Reserved by MedPath